Skip to main content
IRLA logo

IRLA · IRulya Therapeutics Inc. · Holdings

Track IRLA — free
$32.83 -1.85 (-5.33%)
Market Cap
$35.27M
Shares
1.02M
Volume · Oct 22 165.32K Avg daily vol (3M) 37.33K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Recent SEC filings are still being reconciled. Holder totals and changes may be incomplete until processing catches up.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 28
Total Value: $11,253,741
Total Shares: 618,651

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 28 13F filers
Top Holder
37.8%
Sep 2023 → Jun 2026 · range 13.2% – 46.6%
of institutional value
Top 5
81.1%
Sep 2023 → Jun 2026 · range 50.1% – 81.1%
of institutional value
Top 10
96.7%
Sep 2023 → Jun 2026 · range 70.0% – 96.7%
of institutional value
HHI
1,966
Sep 2023 → Jun 2026 · range 656 – 2,552
Moderately concentrated

Who Holds IRLA

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 26 filers, like-for-like change +363.4%; actively managed books +389.2%; index-like books +163.1%.

Holder type Share Filers Change
Registered adviser 86.4% 14 +519.3%
Bank 1.4% 5 +199.8%
Holding company 1.8% 2 +135.9%
Broker-dealer 0.0% 0 -100.0%
Non-US 0.0% 0 -100.0%
Exempt adviser 0.0% 0 —
Benefit plan 0.0% 0 —
Unknown 10.4% 5 +62.7%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

26 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
37.3%
of shares outstanding, 90th percentile
Mar 31, 2026: 18.1%
Private-fund advisers
33.5%
of shares outstanding
Institutional ownership
40.5%
40.9% of the estimated free float
Top 10 holders
96.9%
of 13F shares, Herfindahl 0.162
Active holders
+389.2%
like-for-like share change of active filers
5% stakes on record
7
1 13D, 6 13G (4 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 2.7 quarters
Under 1 year 75.2% 1 to 3 years 22.1% 3 years or more 2.68% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Shared Holders

Companies IRLA's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 BIOA BioAge Labs, Inc. 3
2 ELVN Enliven Therapeutics, Inc. 3
3 COGT Cogent Biosciences, Inc. 3

Shareholder Targets

13F filers that own its peers but not IRLA, quarter ended Jun 30, 2026

Found through its holder-overlap peers: BIOA, ELVN, COGT. 378 filers in all.

# Filer In peers
1 FMR LLC Holding company, Diversified active $1,507,130,172 3 held
2 Polar Capital Holdings Plc Registered adviser, Diversified active $477,751,351 3 held
3 ORBIMED ADVISORS LLC Registered adviser, Diversified active $427,415,654 3 held
4 STATE STREET CORP Bank, Index-like $356,169,459 3 held
5 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $351,015,671 3 held
6 Jupiter Topco LLC Unknown, Diversified active $339,605,762 3 held
7 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $328,150,656 3 held
8 Fairmount Funds Management LLC Registered adviser, Concentrated $307,156,209 2 held
9 Commodore Capital LP Registered adviser, Concentrated $284,241,250 2 held
10 GEODE CAPITAL MANAGEMENT, LLC Registered adviser, Index-like $270,528,232 3 held

Fund Ownership of IRLA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 1.18% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.00% 0
Index ETFs 1.18% 12,044
Active ETFs 0.00% 0
Active funds 0.00% 1
Unclassified 0.00% 0
All registered funds 1.18% 12,045
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 29 of 29
Export CSV
Holder Value (USD) % of 13F Shares Open